Christine Kay AGTC, Foundation Fighting Blindness, Alkeus, Gyroscope, REGENXBIO, Nightstar Therapeutics/Biogen, Spark therapeutics, Novartis, Iveric Bio, ProQR Therapeutics, MeiraGTx, Janssen, Atsena Therapeutics, 4D Molecular Therapeutics, and Kodiak, Code C (Consultant/Contractor);
Isabelle Audo Adelphi Values, Novartis, Sparing Vision, Roche and Biogen, Code C (Consultant/Contractor);
Helena Bradley Adelphi Values, Code E (Employment);
Melissa Barclay Adelphi Values, Code E (Employment);
Joel Sims Adelphi Values, Code E (Employment);
Kieran Boparai Adelphi Values, Code E (Employment);
Francesco Patalano Novartis Pharma AG, Code E (Employment);
Christel Naujoks Novartis Pharma AG, Code E (Employment);
Claudio Spera Novartis Pharma AG, Code E (Employment);
Daniel Viriato Novartis Pharma AG, Code E (Employment);
M Dominik Fischer Adelphi Values, Advent France Biotechnology, Alphasights, Atheneum, Axiom Healthcare Strategies, Biogen, Decision Resources, Dialectica, Frontera Therapeutics, Janssen Research & Development, Navigant, Novartis, Roche, Sirion and STZ eyetrial, Code C (Consultant/Contractor);
Jane Green Adelphi Values, Code C (Consultant/Contractor);
Todd Durham Novartis, Code C (Consultant/Contractor);
Nicola Williamson Adelphi Values, Code E (Employment);
Judit Banhazi Novartis Pharma AG, Code E (Employment)